ALLO’s Financial Health: Exploring Allogene Therapeutics Inc’s Debt-to-Equity Ratio of 1.79
Allogene Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $5.78 on 03/08/24, with the lowest value being $1.78 on 12/20/24. 52-week price history of ALLO Stock Analyzing the 52-week price history of a stock,